• If you are wondering whether Veeva Systems at around US$158.86 is starting to look attractively priced, or if the stock still has more to adjust, this article will walk through what the current valuation signals are really saying.
• The stock has declined 4.5% over the past week, 5.4% over the last month, and is down 27.6% year to date and 34.6% over the past year, which may have some investors rethinking both its potential and its risks.
• These moves have come alongside continuing attention on Veeva Systems as a key software provider to the life sciences industry, with investors weighing how its business model and competitive position fit into a higher-rate world. While company specific headlines may ebb and flow, the share price performance shows that sentiment has been shifting over multiple time frames.
• On Simply Wall St’s valuation framework, Veeva Systems currently scores 4 out of 6 on the undervaluation checks, so next you will see how discounted cash flow, multiples and other methods line up, and then finish with a broader way to think about value that goes beyond any single model.

Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a stock could be worth by projecting the cash the company may generate in the future and discounting those cash flows back to today using a required rate of return.

For Veeva Systems, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is about $1.39b. Analysts provide explicit forecasts for several years, and Simply Wall St then extrapolates further out to build a ten year path. On this basis, projected Free Cash Flow for 2031 is $2.43b, with intermediate years ranging from around $1.33b in 2026 to $3.13b by 2035, all in dollar terms.

After discounting those projected cash flows back to today, the model arrives at an estimated intrinsic value of about $297.51 per share. Compared with the recent share price of around $158.86, this DCF output suggests the stock is 46.6% undervalued based on these assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 46.6%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Veeva Systems Price vs Earnings

For a profitable company, the P/E ratio is a straightforward way to link what you are paying for each share to the earnings that support that price. It reflects what the market is willing to pay today for each dollar of current earnings.

What counts as a “normal” P/E depends on how investors see a company’s growth potential and risk. Higher expected growth and lower perceived risk can justify a higher multiple, while slower expected growth or higher risk usually line up with a lower P/E.

Veeva Systems currently trades on a P/E of 28.52x. That sits above the Healthcare Services industry average of 26.27x and just below the peer average of 29.62x. Simply Wall St’s Fair Ratio for Veeva is 29.06x, which is its view of an appropriate P/E after considering factors like earnings growth, profit margins, industry, market cap and company specific risks. This Fair Ratio aims to be more tailored than a simple comparison with peers or the broad industry because it adjusts for these fundamentals instead of treating all companies as equal.

With Veeva’s actual P/E of 28.52x close to the Fair Ratio of 29.06x, the stock screens as ABOUT RIGHT on this measure.

Result: ABOUT RIGHT

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Veeva Systems Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Meet Narratives, a simple way for you to attach a clear story about Veeva Systems to the numbers you care about. You can link assumptions for future revenue, earnings and margins to a Fair Value that you can compare with today’s price on Simply Wall St’s Community page, where Narratives are used by millions of investors and update automatically when new information like news or earnings arrives. One investor might build a more optimistic Veeva narrative that lines up with a Fair Value of about US$380.00, while another might lean on a more cautious story closer to US$232.80. Both are valid as long as the story, the forecast and the Fair Value stay consistent with each other and with the current share price of around US$158.86.

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.